Ankylosing spondylitis in patient at high gastric ulcer risk

Ankylosing spondylitis in a patient at high gastric ulcer risk refers to active axial spondyloarthritis occurring in an individual with heightened vulnerability to gastrointestinal mucosal injury Ankylosing spondylitis is a chronic, immune-mediated inflammatory arthropathy primarily affecting the axial skeleton—including the sacroiliac joints and spine—characterized by enthesitis, inflammatory back pain, progressive spinal stiffness, and potential bony ankylosis

Ankylosing spondylitis in a patient at high gastric ulcer risk refers to active axial spondyloarthritis occurring in an individual with heightened vulnerability to gastrointestinal mucosal injury The co-occurring high gastric ulcer risk denotes an elevated susceptibility to peptic mucosal ulceration, bleeding, or perforation, commonly driven by risk factors such as advanced age, a history of peptic ulcer disease or gastrointestinal bleeding, or concomitant anticoagulant or corticosteroid therapy...

Ankylosing spondylitis is a chronic, immune-mediated inflammatory arthropathy primarily affecting the axial skeleton—including the sacroiliac joints and spine—characterized by enthesitis, inflammatory back pain, progressive spinal stiffness, and potential bony ankylosis

Ankylosing spondylitis is a chronic, immune-mediated inflammatory arthropathy primarily affecting the axial skeleton—including the sacroiliac joints and spine—characterized by enthesitis, inflammatory back pain, progressive spinal stiffness, and potential bony ankylosis

Ankylosing spondylitis is a chronic, immune-mediated inflammatory arthropathy primarily affecting the axial skeleton—including the sacroiliac joints and spine—characterized by enthesitis, inflammatory back pain, progressive spinal stiffness, and potential bony ankylosis

The co-occurring high gastric ulcer risk denotes an elevated susceptibility to peptic mucosal ulceration, bleeding, or perforation, commonly driven by risk factors such as advanced age, a history of peptic ulcer disease or gastrointestinal bleeding, or concomitant anticoagulant or corticosteroid therapy

Consequently, managing this clinical state requires balancing effective musculoskeletal anti-inflammatory therapy with targeted strategies to mitigate mucosal injury

Consequently, managing this clinical state requires balancing effective musculoskeletal anti-inflammatory therapy with targeted strategies to mitigate mucosal injury